(Q34434809)

2 August 2017

1 reference

title

Dexmethylphenidate extended-release capsules for attention deficit hyperactivity disorder (English)

1 reference

attention deficit hyperactivity disorder

2 August 2017

1 reference

0 references

1 reference

James J McGough

1

1 reference

2 August 2017

Caroly S Pataki

series ordinal

2

1 reference

2 August 2017

Robert Suddath

series ordinal

3

1 reference

2 August 2017

publication date

1 July 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

2 August 2017

published in

1 reference

2 August 2017

volume

5

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

437-441

1 reference

Attention-deficit/hyperactivity disorder in adults: an overview

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Attention deficit/hyperactivity disorder across the lifespan

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

21 January 2018

Stimulant medications

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

New formulations of stimulants for attention-deficit hyperactivity disorder: therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

New drugs for the treatment of attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Extended-release methylphenidate (Ritalin LA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

A post hoc analysis of d-threo-methylphenidate hydrochloride (focalin) versus d,l-threo-methylphenidate hydrochloride (ritalin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Advances in the Pharmacotherapy of Attention‐Deficit‐Hyperactivity Disorder: Focus on Methylphenidate Formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Evidence that methylphenidate enhances the saliency of a mathematical task by increasing dopamine in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Stereoselective effects of methylphenidate on motor hyperactivity in juvenile rats induced by neonatal 6-hydroxydopamine lesioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Neurobehavioral effects of racemic threo-methylphenidate and its D and L enantiomers in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Stereospecific distribution of methylphenidate enantiomers in rat brain: specific binding to dopamine reuptake sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and L-threo-methylphenidate in the human and baboon brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

Brain kinetics of methylphenidate (Ritalin) enantiomers after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.4.437

21 January 2018

Identifiers

DOI

10.1586/14737175.5.4.437

1 reference

2 August 2017

1 reference